Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2000
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365540A1 A novel complex of human kallikrein 2 (hk2) and protease inhibitor-6 (pi-6) in prostate tumor tissue and methods of using the complex
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2364650A1 50 human secreted proteins
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364630A1 50 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2363019A1 49 human secreted proteins
09/21/2000CA2361277A1 49 human secreted proteins
09/20/2000EP1036188A1 ribG
09/20/2000EP1036179A1 Method for preparing polypeptides with appropriate glycosilation
09/20/2000EP1036177A1 Novel vectors and genes exhibiting increased expression
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036167A2 Nuclear targeting by means of streptococcal protein h
09/20/2000EP1036087A1 Secreted proteins and polynucleotides encoding them
09/20/2000EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
09/20/2000EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same
09/20/2000EP1035861A1 Threonine-containing protegrins
09/20/2000EP1035856A1 Isolated dna encoding human h3 histamine receptor
09/20/2000EP1035780A1 Method for purifying heat shock peptides complexes
09/20/2000EP0854883A4 Developmentally-regulated endothelial cell locus-1
09/20/2000EP0792291B1 Protein affecting katp channels
09/20/2000EP0766735B1 Class bi and ci scavenger receptors
09/20/2000EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis
09/20/2000EP0672057B1 Analogs of pth
09/20/2000EP0586549B1 Selecting ligand agonists and antagonists
09/20/2000EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267223A Carcinostatic agents
09/20/2000CN1266907A Process for preparing bisegmentum and monosegmentum of monoclone antibody
09/20/2000CN1266906A Process and equipment for preparing low-molecular peptide from sodium caseinate as raw material
09/20/2000CN1266903A Recombined xylanase, its preparing process and its application
09/20/2000CN1266902A Human membrane translocator and its coding sequence
09/20/2000CN1266901A I-type isomer of human steroid 5 alpha reductase and its coding sequence
09/20/2000CN1266899A Precursor heteromorphic protein of human calcium binding protein and its coding sequence
09/20/2000CN1056618C Acylated insulin and pharmaceutical composition contg. same
09/20/2000CN1056617C Melanoma-inhibiting protein
09/20/2000CN1056616C Membrane protein polypeptide having supporting pre-B cell growth and gene thereof
09/19/2000US6121428 Protein recovery
09/19/2000US6121427 Major outer membrane protein CD of branhamella
09/19/2000US6121426 Fibrin binding domain polypeptides and uses and methods of producing same
09/19/2000US6121425 Metal-lipid molecules
09/19/2000US6121424 Immunogen association polypeptides with at least two preferences; for the delivery of cells, cytotoxins, or drugs to preferential positioning
09/19/2000US6121423 Polypeptide light chain of an immunoglobulin; for the treatment and prevention of autoimmune diseases, glomerulonephritis and myelomas; antitumor agents
09/19/2000US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
09/19/2000US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis
09/19/2000US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof
09/19/2000US6121003 Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use
09/19/2000US6120989 Isolated human cytomegalovirus polypeptides and uses thereof
09/19/2000US6120776 Kit containing vaccine and diagnostic test
09/19/2000US6120773 Recombinant herpes simplex viruses vaccines and methods
09/19/2000US6120767 Genetic engineering
09/19/2000US6120765 Purified peptide
09/19/2000US6120764 Genetic engineering
09/19/2000CA2079187C Cyclohexapeptidyl bisamine compounds
09/19/2000CA2050601C Production in bacteria and yeast of hemoglobin and analogues thereof
09/17/2000CA2300782A1 Modified factor viii cdna
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053731A2 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration
09/14/2000WO2000053725A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053623A1 Bifunctional molecules for delivery of therapeutics
09/14/2000WO2000053232A1 Matriptase, a serine protease and its applications
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000037504A3 Human monoclonal antibodies to ctla-4
09/14/2000WO2000037102A3 Improvement of tolerance to a xenograft
09/14/2000WO2000035409A3 Hiv-i fusion inhibition compounds
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000031132A8 Novel polypeptide
09/14/2000WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
09/14/2000WO2000023588B1 G-protein coupled receptors
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000CA2478736A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478730A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478728A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367334A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2366706A1 Mammalian cytokines; related reagents and methods
09/14/2000CA2366689A1 Bifunctional molecules for delivery of therapeutics
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2362670A1 Matriptase, a serine protease and its applications
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1125